Long-term use of adalimumab in the treatment of rheumatic diseases
Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A DrososRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceAbstract: Adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor-alpha (TNF&alph...
Saved in:
Main Authors: | Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A Drosos |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/43f28b6a51da4deab3b66a59004132da |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term treatment of rheumatoid arthritis with adalimumab
by: Murdaca G, et al.
Published: (2013) -
The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
by: Reimold AM
Published: (2012) -
Efficacy and safety of adalimumab in ankylosing spondylitis
by: Mounach A, et al.
Published: (2014) -
Certolizumab in the long-term treatment of rheumatoid arthritis
by: Scott DL, et al.
Published: (2011) -
Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases
by: Perez Alamino R, et al.
Published: (2012)